Exchange: NASDAQ·Updated 07:30 PM EDT
News
all
press releases
Veru (VERU) Q3 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
More News
This Small-Cap Biotech Just Soared Over 160% — What Is The Novo Nordisk Connection?
Veru will evaluate enobosarm alongside Novo Nordisk’s Wegovy in the Phase 2b PLATEAU trial in older adults with obesity.
Stocktwits
Earnings call transcript: Veru Inc Q2 2026 shows improved financials
Press Releases
Veru (VERU) Q1 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
A Look Ahead: Veru's Earnings Forecast
read more...
Benzinga
Top Wall Street Forecasters Revamp Veru Expectations Ahead Of Q4 Earnings
read more...
Benzinga
Veru Announces Novel Modified-Release Oral Formulation for Enobosarm
VERU unveils a novel modified-release oral enobosarm to enhance fat loss while preserving lean mass in chronic weight loss management.
Zacks

Advertisement|Remove ads.